Acute lymphoblastic leukemia
Conditions
Interventions
Normal temperature group (observation group) and the fever group (control group):none
Sponsors
Shenzhen Children’s Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: 1.The child was diagnosed with acute lymphoblastic leukemia; 2.The treatment plan and risk grouping criteria were based on CCCG-AlL-2020 Childhood acute lymphoblastic leukemia treatmentprotocol; 3.Their age ranged from 1 month to 18 years; 4.All patients were newly diagnosed; 5.The body temperature was normal prior to chemotherapy. 6.The patient demonstrates excellent compliance, meaning they are capable of completing the stipulated treatment protocol and cooperating with relevant examinations and follow-ups.
Exclusion criteria
Exclusion criteria: 1.Mature B-ALL, mixed leukemia; 2.Combined with other tumors; 3.Combined with autoimmune diseases; 4.Children with incomplete diagnosis and treatment data;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White blood cell(WBC);Neutrophil (NEU);Hypersensitive C-reactive protein;Interleukin- 6;Procalcitonin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total bilirubin;Aspartate aminotransferase;Alanine aminotransferase;Total Protein;Creatinine;Urea; | — |
Countries
China
Contacts
Public ContactXuejuan Li
Shenzhen Children’s Hospital
Outcome results
None listed